Biocon Biologics crosses 100 million insulin cartridge deliveries in Malaysia
Biocon Biologics Ltd. (BBL), through its Malaysian arm Biocon Sdn. Bhd., has delivered over 100 million cartridges of recombinant human insulin (rh-insulin) to Malaysia's Ministry of Health (MoH). The company has been supplying insulin to Malaysia since 2016, supporting diabetes management efforts across the country.
As part of a long-standing public-private partnership with the Malaysian government, Biocon Biologics has helped serve around 345,000 patients by making rh-insulin more accessible. The collaboration is aimed at supporting local healthcare needs through stable supply and improved access to affordable insulin therapy.
The company's insulin manufacturing facility in Johor, established with a cumulative investment of $600 million since 2011, functions as a Center of Excellence (CoE) for insulin production. The facility is equipped to manufacture various types of insulin—regular, basal, and rapid-acting—in formats such as cartridges and delivery devices. The site has been acknowledged by the Malaysia Book of Records as the country's first and largest integrated insulin manufacturer.
Globally, Biocon Biologics has distributed over 9.2 billion doses of rh-Insulin and Insulin Glargine to patients, as part of its wider effort to support insulin access worldwide.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
30 minutes ago
- Business Upturn
ArisInfra Solutions shares surge 6% after subsidiary bags project in Bangalore's Nandi Hills
Shares of ArisInfra Solutions jumped 6% after its subsidiary, ArisUnitern RE Solutions Pvt. Ltd. (AUPL), secured a significant Development Management project in the high-growth Nandi Hills region of Bangalore. As of 11:12 AM, the shares were trading Rs 169.54 higher at Rs 5.91%. The project, commissioned by Village Wave Pvt. Ltd., spans 21.93 acres with a Gross Development Value (GDV) of approximately ₹288 crore. AUPL has been awarded exclusive rights to supply all construction materials and deliver end-to-end development management services, including project monitoring, sales, and collections. This contract is expected to add nearly ₹100 crore to ArisInfra's consolidated order book, further enhancing the company's asset-light, high-margin business model. The project win also reinforces ArisInfra's strategy of collaborating with developers and contractors to secure exclusive supply agreements and expand its distribution network. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
New York Post
2 hours ago
- New York Post
Young New Orleans cop and Army Reservist dies after undergoing risky but popular cosmetic surgery: ‘unnecessary for her to die'
A young New Orleans police officer has died days after undergoing a Brazilian butt lift and complaining of 'extreme pain' following the risky cosmetic procedure. Wildelis Rosa, 26, told her family she was traveling from New Orleans to Miami for her birthday in March, unaware that she planned to undergo the nip and tuck operation, her older sister, Anamin Vazquez, told NBC6. Rosa — who was also a US Army Reservist who had just come back from deployment in Kuwait — had her pre-operative blood work done at Prestige Plastic Surgery Clinic in South Florida on March 19, and the following day, doctors removed fat from 12 areas around her body and injected it into the buttocks. Advertisement 5 Wildelis Rosa died days after undergoing a Brazilian butt lift and complaining of 'extreme pain' following the risky cosmetic procedure. Jam Press/New Orleans Police Department An invoice for her Brazilian butt lift, commonly referred to as BBL, shows Rosa paid $7,495 for the cosmetic procedure, which typically ranges from $6,000 to $18,000 in the US but is known to be notoriously cheaper in Miami. Rosa was recovering at a short-term rental and told her family about her BBL three days after the surgery. Advertisement However, Vazquez said they immediately had a feeling 'in our guts like something is wrong.' 'I texted her and I said, 'I hope you're doing okay you're enjoying your birthday.' But there was no answer back,' Vazquez said. The next morning, on March 23, an unidentified friend staying with Rosa found her unresponsive after she collapsed in the bathroom. They immediately performed CPR on her, but she was already gone. 5 Rosa was also a US Army Reservist who had just come back from deployment in Kuwait. Jam Press Advertisement The Miami-Dade Medical Examiner ruled her cause of death as a pulmonary embolism from blood clots associated with cosmetic surgery, NBC6 reported. Her friend told the medical examiner that Rosa went for a follow-up appointment the day after her surgery, where she complained of 'extreme pain,' and while at their rental, she was having difficulty breathing and her blood pressure had been 'drastically' dropping. The day before her death, her friend also noted she appeared pale, had dilated pupils, her lips appeared purple, and she said she had no feeling in her legs or feet. 5 Rosa had her pre-operative blood work done at Prestige Plastic Surgery Clinic in South Florida on March 19, and the following day, doctors removed fat from 12 areas around her body and injected it into the buttocks. Jam Press Advertisement Rosa's heartbroken sister shared that Rosa also texted another friend the night before her death, complaining about her blood pressure and circulation issues in her feet. Vazquez believes that if these warning signs had been addressed, her baby sister could still be with them. 'It's that's the part that we have to live with because it was unnecessary for her to die…to die like that,' she said, noting her sister, the youngest of five siblings, had had hopes of working for the FBI one day before her life was cut short. Rosa's demise marks a string of deaths related to cosmetic surgeries in Miami, NBC6 reported. 5 The day before her death, a friend staying with Rosa said she appeared pale, had dilated pupils, her lips appeared purple, and she said she had no feeling in her legs or feet. Jam Press 5 Her older sister believes that if these warning signs had been addressed, Rosa could still be with them. Jam Press/New Orleans Police Department The Miami-Dade Medical Examiner's Office has certified 25 deaths due to complications with cosmetic procedures, involving several different doctors and clinics over the last three and a half years. Brazilian butt lifts have been around since the 1960s but gained significant popularity in the 2010s — largely driven by social media trends and celebrity influence — with a 30% increase in procedures between 2014 and 2015, according to the American Society of Plastic Surgeons. Advertisement In 2024, nearly 30,000 BBL surgeries were performed in the US, representing 28% of all cosmetic procedures in the US. However, despite its popularity, the cosmetic surgery has one of the highest mortality rates, with roughly 1 in 15,000 patients dying since safety guidelines were strictly enforced in 2019, according to the National Library of Medicine. The primary causes of death associated with BBLs are fat embolism and venous thromboembolism, where fat is injected into blood vessels and can travel to the lungs or other organs.
Business Upturn
2 hours ago
- Business Upturn
Godavari Biorefineries share hits 5% upper circuit on Europe patent win for novel anti-cancer molecule
By Aman Shukla Published on July 4, 2025, 09:31 IST Shares of Godavari Biorefineries surged 5% and hit the upper circuit on July 4, following a key announcement regarding a major breakthrough in its anti-cancer research efforts. In a regulatory filing to the NSE and BSE, the company revealed that it has been granted a European patent for its novel anti-cancer molecule, which has demonstrated high potency against both cancer cells and cancer stem cells. This compound is now officially validated in Spain, the UK, and as a Unitary Patent across Europe. The development falls under the company's 'Anti-Cancer Research Segment', highlighting its focus on cutting-edge oncology innovation. According to the company, this patent not only strengthens its intellectual property portfolio but also reinforces its commitment to developing next-generation cancer therapies. Investors responded positively to the news, sending the stock to its daily upper limit. The development is seen as a significant milestone, potentially opening doors for future collaborations, licensing deals, and expansion into global pharmaceutical markets. This is part of Godavari Biorefineries' broader strategy to diversify into high-value bio-based research areas, beyond its traditional ethanol and bio-chemicals business. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
